Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
第一作者:
Ya,Xie
第一单位:
Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China.
作者:
主题词
抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌(Carcinoma);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);药物评价, 临床前(Drug Evaluation, Preclinical);子宫内膜肿瘤(Endometrial Neoplasms);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);降血糖药(Hypoglycemic Agents);醋酸甲羟孕酮(Medroxyprogesterone Acetate);二甲双胍(Metformin);模型, 生物学(Models, Biological);受体, 孕酮(Receptors, Progesterone);信号传导(Signal Transduction);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases)
DOI
10.1016/j.jsbmb.2010.12.006
PMID
21168492
发布时间
2021-12-03
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文